NCT01653392 2024-03-15
BioThrax® (Anthrax) Vaccine in Pregnancy Registry
Emergent BioSolutions
Completed
Clinical Trials
3 trialsNCT01290393 2018-07-26
Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada
GlaxoSmithKline
Terminated
NCT01905462 2013-09-30
Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK
GlaxoSmithKline
Completed